Rating History for Genmab A/S (GMAB) by Morgan Stanley

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
10/20/2026 Sean Laaman New Coverage Equalweight
(N/A)
42.00
(N/A)
37.00
(43.79)
18.35% Details